Preview of a biomarker developer’s planned conference program highlighting presentations and partner engagements across diagnostics and critical care events.
Key Takeaways
- SphingoTec will present new multicenter penKid sepsis data as a poster at ESICM Lives 2026
- Abstract at ASN Kidney Week 2026 reports proenkephalin predicts severe AKI in high-risk patients
- SphingoTec will co-host a scientific symposium on sepsis diagnostics with partner Boditech in Lisbon